John C W Lim (John Cw Lim)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Health Information

Peritoneal Dialysis

Decision Making

Transcription Factor

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kavitha Palaniappan, Elaine Yan Ting Lin, Silke Vogel, John C W Lim
Gaps in the Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector and Key Recommendations. Healthcare (Basel, Switzerland) 12 (17) (2024)
Richard Hatchett, Mei Xuan Jessalyn Chan, Adam Hacker, Wei Chuen Tan-Koi, Silke Vogel, John C W Lim
Regulation in the age of calamity: Changing the regulatory paradigm. Clinical and translational science 17 (7) (2024)
Richard Hatchett, Mei Xuan Jessalyn Chan, Adam Hacker, Wei Chuen Tan-Koi, Silke Vogel, John C W Lim
Regulation in the age of calamity: Changing the regulatory paradigm. Clinical and translational science 17 (7) (2024)
Penny M Heaton, Kavitha Palaniappan, Anne-Claire Stona, Silke Vogel, John C W Lim
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective. Clinical pharmacology and therapeutics (2023)
Yoong Khean Khoo, John C W Lim, Wei Chuen Tan-Koi, Nokuthula Sikhethiwe Kitikiti, Ai Ling Sim-Devadas
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making. Drug safety (2023)
Alexander R Giaquinto, Alberto Grignolo, Lawrence Liberti, John C W Lim, Tomas Salmonson, Fernand Sauer, Henrietta Ukwu
Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative. PLoS medicine 17 (8) (2020)
John C W Lim, Cheng-Leng Chan, Andrew Green
Global Challenges in Regulatory Capacity and Capability Building: Extrapolating Lessons Learned From the HSA. Clinical pharmacology and therapeutics 105 (4) (2018)